170 related articles for article (PubMed ID: 33941126)
1. Time trends in HPV vaccination according to country background: a nationwide register-based study among girls in Norway.
Bjerke RD; Laake I; Feiring B; Aamodt G; Trogstad L
BMC Public Health; 2021 May; 21(1):854. PubMed ID: 33941126
[TBL] [Abstract][Full Text] [Related]
2. Do parental education and income matter? A nationwide register-based study on HPV vaccine uptake in the school-based immunisation programme in Norway.
Feiring B; Laake I; Molden T; Cappelen I; Håberg SE; Magnus P; Steingrímsdóttir ÓA; Strand BH; Stålcrantz J; Trogstad L
BMJ Open; 2015 May; 5(5):e006422. PubMed ID: 25991445
[TBL] [Abstract][Full Text] [Related]
3. HPV vaccination and risk of chronic fatigue syndrome/myalgic encephalomyelitis: A nationwide register-based study from Norway.
Feiring B; Laake I; Bakken IJ; Greve-Isdahl M; Wyller VB; Håberg SE; Magnus P; Trogstad L
Vaccine; 2017 Jul; 35(33):4203-4212. PubMed ID: 28648542
[TBL] [Abstract][Full Text] [Related]
4. Mode of HPV vaccination delivery and equity in vaccine uptake: A nationwide cohort study.
Wang J; Ploner A; Sparén P; Lepp T; Roth A; Arnheim-Dahlström L; Sundström K
Prev Med; 2019 Mar; 120():26-33. PubMed ID: 30593796
[TBL] [Abstract][Full Text] [Related]
5. Correlates of HPV vaccine uptake in school-based routine vaccination of preadolescent girls in Norway: A register-based study of 90,000 girls and their parents.
Hansen BT; Campbell S; Burger E; Nygård M
Prev Med; 2015 Aug; 77():4-10. PubMed ID: 25944266
[TBL] [Abstract][Full Text] [Related]
6. Socioeconomic predictors of human papillomavirus vaccination among girls in the Danish childhood immunization program.
Slåttelid Schreiber SM; Juul KE; Dehlendorff C; Kjær SK
J Adolesc Health; 2015 Apr; 56(4):402-7. PubMed ID: 25659994
[TBL] [Abstract][Full Text] [Related]
7. Substantial Decline in Prevalence of Vaccine-Type and Nonvaccine-Type Human Papillomavirus (HPV) in Vaccinated and Unvaccinated Girls 5 Years After Implementing HPV Vaccine in Norway.
Feiring B; Laake I; Christiansen IK; Hansen M; Stålcrantz J; Ambur OH; Magnus P; Jonassen CM; Trogstad L
J Infect Dis; 2018 Nov; 218(12):1900-1910. PubMed ID: 30010913
[TBL] [Abstract][Full Text] [Related]
8. Factors influencing uptake of HPV vaccination among girls in Germany.
Schülein S; Taylor KJ; König J; Claus M; Blettner M; Klug SJ
BMC Public Health; 2016 Sep; 16():995. PubMed ID: 27645711
[TBL] [Abstract][Full Text] [Related]
9. Improving skills and institutional capacity to strengthen adolescent immunisation programmes and health systems in African countries through HPV vaccine introduction.
Dochez C; Burnett RJ; Mbassi SM; Were F; Musyoki A; Trovoada D; Mphahlele MJ
Papillomavirus Res; 2017 Dec; 4():66-71. PubMed ID: 29179872
[TBL] [Abstract][Full Text] [Related]
10. Model-based impact and cost-effectiveness of cervical cancer prevention in the Extended Middle East and North Africa (EMENA).
Kim JJ; Sharma M; O'Shea M; Sweet S; Diaz M; Sancho-Garnier H; Seoud M
Vaccine; 2013 Dec; 31 Suppl 6():G65-77. PubMed ID: 24331822
[TBL] [Abstract][Full Text] [Related]
11. Knowledge about cervical cancer and HPV immunization dropout rate among Brazilian adolescent girls and their guardians.
Santos ACDS; Silva NNT; Carneiro CM; Coura-Vital W; Lima AA
BMC Public Health; 2020 Mar; 20(1):301. PubMed ID: 32143614
[TBL] [Abstract][Full Text] [Related]
12. Identification of determinants associated with uptake of the first dose of the human papillomavirus vaccine in Denmark.
Amdisen L; Kristensen ML; Rytter D; Mølbak K; Valentiner-Branth P
Vaccine; 2018 Sep; 36(38):5747-5753. PubMed ID: 30111513
[TBL] [Abstract][Full Text] [Related]
13. The contagious nature of a vaccine scare: How the introduction of HPV vaccination lifted and eroded MMR vaccination in Denmark.
Gørtz M; Brewer NT; Hansen PR; Ejrnæs M
Vaccine; 2020 Jun; 38(28):4432-4439. PubMed ID: 32418796
[TBL] [Abstract][Full Text] [Related]
14. An observational study comparing HPV prevalence and type distribution between HPV-vaccinated and -unvaccinated girls after introduction of school-based HPV vaccination in Norway.
Enerly E; Flingtorp R; Christiansen IK; Campbell S; Hansen M; Myklebust TÅ; Weiderpass E; Nygård M
PLoS One; 2019; 14(10):e0223612. PubMed ID: 31600341
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus vaccine uptake in boys and girls in a school-based vaccine delivery program in Prince Edward Island, Canada.
McClure CA; MacSwain MA; Morrison H; Sanford CJ
Vaccine; 2015 Apr; 33(15):1786-90. PubMed ID: 25731789
[TBL] [Abstract][Full Text] [Related]
16. Asking about human papillomavirus vaccination and the usefulness of registry validation: a study of young women recruited using Facebook.
Gunasekaran B; Jayasinghe Y; Brotherton JM; Fenner Y; Moore EE; Wark JD; Fletcher A; Tabrizi SN; Garland SM
Vaccine; 2015 Feb; 33(6):826-31. PubMed ID: 25444782
[TBL] [Abstract][Full Text] [Related]
17. Community-based household assessment of human papillomavirus (HPV) vaccination coverage and acceptability - HPV vaccine demonstration program, Cambodia - 2017.
Garon J; Wuddhika IV; Sreenivasan N; Wannemuehler K; Vutthikol Y; Chhorvann C; Loharikar A
Vaccine; 2019 Feb; 37(9):1202-1208. PubMed ID: 30686637
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus (HPV) vaccine coverage achievements in low and middle-income countries 2007-2016.
Gallagher KE; Howard N; Kabakama S; Mounier-Jack S; Burchett HED; LaMontagne DS; Watson-Jones D
Papillomavirus Res; 2017 Dec; 4():72-78. PubMed ID: 29179873
[TBL] [Abstract][Full Text] [Related]
19. Estimate of global human papillomavirus vaccination coverage: analysis of country-level indicators.
Spayne J; Hesketh T
BMJ Open; 2021 Sep; 11(9):e052016. PubMed ID: 34475188
[TBL] [Abstract][Full Text] [Related]
20. The impact of HPV multi-cohort vaccination: Real-world evidence of faster control of HPV-related morbidity.
Orumaa M; Kjaer SK; Dehlendorff C; Munk C; Olsen AO; Hansen BT; Campbell S; Nygård M
Vaccine; 2020 Feb; 38(6):1345-1351. PubMed ID: 31917039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
